No Data
Vanda Will Request Relief From Court That Includes Order Requiring Defendants to Discontinue Marketing Generic Versions of HETLIOZ >VNDA
Vanda Will Request Relief From Court That Includes Order Requiring Defendants to Discontinue Marketing Generic Versions of HETLIOZ >VNDA
Vanda Intends to Proceed With Discovery in the Case to Continue Pursuing Its Claims >VNDA
Vanda Intends to Proceed With Discovery in the Case to Continue Pursuing Its Claims >VNDA
Vanda: Court Concluded Issues of Patentability Weren't Same as Those Resolved in Prior Patent-Infringement Litigation Between Parties >VNDA
Vanda: Court Concluded Issues of Patentability Weren't Same as Those Resolved in Prior Patent-Infringement Litigation Between Parties >VNDA
Vanda: Court Denied Motions for Judgment on Pleadings That Were Filed by Teva Pharmaceuticals USA and Apotex >VNDA
Vanda: Court Denied Motions for Judgment on Pleadings That Were Filed by Teva Pharmaceuticals USA and Apotex >VNDA
What's Going On With Vanda Pharmaceuticals Shares Today?
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares are trading lower after Future Pak withdrew its proposal to purchase the company."Consistent with the position indicated in its June 13, 2024 letter to
Future Pak Late Wednesday Announced The Withdrawal Of Its Proposal To Purchase Vanda Pharmaceuticals Inc.
Future Pak Late Wednesday Announced The Withdrawal Of Its Proposal To Purchase Vanda Pharmaceuticals Inc.